Huge Recall on Epinephrine Injectors: What Moms of Kids With Allergies Need to Know

Auvi-Q epinephrine injection recallSanofi is recalling all Auvi-Q injectors in the United States. The voluntary recall of close to 490,000 products includes the 0.15 mg and 0.3 mg strengths, and lot number 2299596 through 3037230 with an expiration date from March 2016 through December 2016.

Advertisement

Auvi-Q, a product commonly used during allergic emergencies and life-threatening allergic reactions, has been recalled, as the manufacturer believes it doesn't deliver the correct dosage. In their press release, Sanofi notes the potential for serious health consequences -- including death, should patients suffer from a life-threatening condition -- if users receive an incorrect dose.

Since October 26, Sanofi received 26 reports of products with suspected device malfunction, and while Sanofi says they haven't been confirmed, they are taking necessary precautions.

No deaths have been reported.

In the company announcement, Sanofi states customers with proof of purchase will receive reimbursement for money spent out-of-pocket to buy new epinephrine auto-injectors. Consumers are also urged to contact their health-care provider as soon as possible to get a prescription for an alternative injector -- and for any issues related to taking Auvi-Q.

More from The Stir: 10 Things Never to Say to a Mom of a Kid With Food Allergies

Sanofi will continue to notify consumers and distributors about their recall, and recommend those with questions contact them via phone (call 1-866-726-6340 Monday through Friday, between 8 a.m. to 8 p.m. EST) or email (cs@sanofi.com). You can also visit their website, www.Auvi-Q.com, for more information -- including details about reimbursement when made available.

Users can also report problems experienced with Auvi-Q to the FDA's MedWatch Adverse Event Reporting program. You can submit a report online, or download a form to mail or fax.

 

 

Image via Auvi-Q.com

Read More >

recalls